101BHG-D01 / Beijing Shuobai Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
101BHG-D01 / Beijing Shuobai Pharma
ChiCTR2200065138: A multicenter, randomized, double-blind, placebo, parallel controlled phase II clinical study to evaluate the efficacy and safety of 101BHG-D01 nasal spray in patients with runny nose caused by colds

Not yet recruiting
2
120
 
patients receive 160μg each time ;patients receive 320μg each time ;patients receive 0μg each time
Peking University Third Hospital; BEIJING SHOWBY PHARMACEUTICAL CO., LTD, Sponsor supply
runny nose caused by colds
 
 

Download Options